LRP1B and neoplasm: We found that co-mutation of FAT3 and LRP1B has prominent significance, which can increase somatic mutational load, boost cytotoxicity and tumor immunogenicity, facilitate lymphocyte infiltration in the microenvironment, and significantly influence the outcome of immunotherapy.